BIOMAT Database Logo BIOMAT Database Logo

Induction VBM plus radiotherapy, versus radiotherapy alone for advanced head and neck cancer: long-term results. 1989

M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
Department of Otolaryngology, Royal Liverpool Hospital, UK.

Between 1978 and 1981, 85 patients with advanced squamous cell carcinoma of the head and neck were randomized to receive induction VBM followed by radiotherapy, or radiotherapy alone. The shortest follow-up is thus 6 years. The median survival of patients receiving induction chemotherapy was 46 weeks, that of the radiotherapy group alone was 75 weeks. As the two groups were not balanced despite randomization, multivariate methods (GLIM) were used to identify significant prognostic factors. These were: response to radiotherapy (P less than 0.001), nodal status (P less than 0.001), age (P less than 0.01), and histological grade (P less than 0.01). Neither treatment with, nor response to, chemotherapy had a significant effect on survival.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
Long-term results of VBM and radiotherapy in advanced head and neck cancer.
September 1982, International journal of radiation oncology, biology, physics,
M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
Advanced head and neck cancer: long-term results of chemo-radiotherapy, complications and induction of second malignancies.
December 2001, Onkologie,
M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
Advanced head and neck cancer treated by combined radiotherapy and VBM cytotoxic regimen--four-year results.
October 1979, Clinical otolaryngology and allied sciences,
M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
The long-term outcome after radical radiotherapy for advanced head and neck cancer.
January 1993, Clinical oncology (Royal College of Radiologists (Great Britain)),
M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
Chemo-radiotherapy for locally advanced head and neck cancer--long-term results of a phase II trial.
June 1997, European journal of cancer (Oxford, England : 1990),
M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
April 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
Long-term results of accelerated radiation treatment for advanced head and neck cancer.
October 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.
November 2008, Clinical oncology (Royal College of Radiologists (Great Britain)),
M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer.
December 1993, Annals of oncology : official journal of the European Society for Medical Oncology,
M Z Siodlak, and J E Dalby, and P J Bradley, and J B Campbell, and P Strickland, and J G Fraser, and D J Willatt, and L M Flood, and P M Stell
Docetaxel plus radiotherapy for head and neck cancer.
April 2023, Oral oncology,
Copied contents to your clipboard!